Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Clin Perinatol. 2015 May 23;42(3):557–566. doi: 10.1016/j.clp.2015.04.016

Table 3.

Infant characteristics and neurodevelopmental outcomes from ESA RCT

Darbe (n=27) Epo (n=29) Placebo (n=24) p Adjusted Odds Ratio p
Birth Weight (grams) 938.3 ± 176.5 947.2 ± 212.7 953.0 ± 210.0 NS
Gestation (weeks) 28.1 ± 1.8 27.8 ± 1.9 27.8 ± 1.6 NS
Corrected age at follow up (months) 20.5 ± 1.1 21.2 ± 2.0 20.6 ± 1.9 NS
Composite cognitive 96.2±7.5 97.9±14.0 88.7±13.3 0.01
Composite language 92.4±12.8 89.9±17.4 83.6±13.9 0.05
Object permanence 2.8±0.4 2.4±0.8 2.2±1.0 0.05

Neurodevelopmental Impairment: 3 (11%) 2 (7%) 9 (38%) 0.18 (0.05 to 0.63) 0.01
 Cerebral Palsy (%) 0 (0) 0 (0) 5 (21) 0.002 0 (0 to 0) <0.001
 Visual deficit (%) 1 (4) 0 (0) 1 (4) 0.09 0.23 (0.04 to 1.54) NS
 Hearing deficit (%) 0 1 (3) 1 (4) 0.33 0.54 (0.11 to 2.65) NS
Composite Cognitive Score<85 0 3 (10.3%) 6 (25%) 0.02 0.18 (0.04 to 0.78) 0.01
Composite Cognitive Score<70 0 1 (3.4%) 2 (8.3%) 0.29

Odds Ratios adjusted for gender. Values represent mean±SD or number (percent). P values represent three way comparisons among groups.